Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
4
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(3)
Other(1)

Detailed Status

Completed3
unknown1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

completed375%
unknown125%

Recent Activity

0 active trials
Showing 4 of 4
completednot_applicable

Aflibercept anD navigateD vErsus coNvensional Laser in Diabetic macUlar edeMa

NCT02554747
completednot_applicable

Pattern Laser Versus Conventional Laser in Diabetic Retinopathy

NCT03672656
completednot_applicable

PASCAL Laser Platform Produces Less Pain Responses Compared To Conventional Laser System

NCT02645383
unknownnot_applicable

To Compare Visual Field Impairment in Conventional Double Frequency Nd: YAG Panretinal Photocoagulation With PASCAL Panretinal Photocoagulation

NCT01023113

Clinical Trials (4)

Showing 4 of 4 trials
NCT02554747Not Applicable

Aflibercept anD navigateD vErsus coNvensional Laser in Diabetic macUlar edeMa

Completed
NCT03672656Not Applicable

Pattern Laser Versus Conventional Laser in Diabetic Retinopathy

Completed
NCT02645383Not Applicable

PASCAL Laser Platform Produces Less Pain Responses Compared To Conventional Laser System

Completed
NCT01023113Not Applicable

To Compare Visual Field Impairment in Conventional Double Frequency Nd: YAG Panretinal Photocoagulation With PASCAL Panretinal Photocoagulation

Unknown

All 4 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
4